How to invest
Below you can find answers to the most common questions when it comes to buying or selling shares in the funds. If you need further information, please contact us at info@rhepa.com.
Important information
Please note that Rhenman & Partners is solely the portfolio manager of the funds. Rhenman & Partners is not authorized to provide – and will not provide – investment recommendations to investors.
We strongly urge you to read the fact sheet and information brochure for the funds before making an investment decision.
Historical returns are not a guarantee of future returns. The money you invest in the fund can both decrease and increase in value and you may not get back all the invested capital.
How can I invest?
It is possible to invest in the fund through a bank, intermediary or fund platform. It is not possible to invest directly through Rhenman & Partners.
How often are the funds traded and when is the cut-off time?
The funds are traded once a month. The fund administrator's cut-off time occurs three days prior to the last (Luxembourg) business day of each month. Please note that your bank, intermediary or fund platform may have an earlier deadline for orders. Hence, it is important to check their specific cut-off time.
When is money transferred after a redemption?
The settlement from the fund administrator takes place five business days after month end. Please note that your bank, intermediary or fund platform may need a few extra days to handle the transaction.
What makes a hedge fund different from a long only equity fund?
The more liberal investment rules for hedge funds give us more flexible investment opportunities compared to ordinary mutual funds. Rhenman Healthcare Equity L/S is mainly invested in equities, both long and short positions. We do not benchmark ourselves against an equity index, the target is a positive annual return regardless of stock market performance.
How is the performance fee for the funds calculated?
The performance fee for the fund’s broadly distributed share classes is calculated on a quarterly basis. This means that the performance fee is due if the hurdle NAV (net asset value) of the share class, at the time of the calculation, has reached a new highest level at the end of a quarter. Given that the review period for performance fees is quarterly, it may be worth noting that a performance fee can be charged at one or more quarterly closures, when the NAV has developed positively, even though the performance for the calendar year as a whole may turn out to be negative.
Which share classes are available?
See list of share classes below.
In which countries is RHELS registered?
Rhenman Healthcare Equity L/S is an AIF which is available to retail investors in Sweden and Finland only, and it is registered for professional investors only in Belgium, Finland, the Netherlands, Italy, Sweden, the United Kingdom, Singapore with restricted scheme offered to accredited investors only and Switzerland (distributed without FINMA registration).